Ipatasertib

DB11743InvestigationalSmall molecule

Ipatasertib has been used in trials studying the treatment of Cancer, Neoplasms, Solid Cancers, Breast Cancer, and Gastric Cancer, among others.

Chemical structure of Ipatasertib
Formula / weight
C24H32ClN5O2 · 457.996 g/mol (avg)
Code names
GDC-0068 · RG-7440 · RO5532961

Resolves to

Compound
UNII524Y3IB4HQCAS1001264-89-6ChEMBLCHEMBL2177390ChEBI95089PubChem24788740
Structure
InChIKeyGRZXWCHAXNAUHY-NSISKUIASA-NSMILES[H][C@](CNC(C)C)(C(=O)N1CCN(CC1)C1=NC=NC2=C1[C@]([H])(C)C[C@@]2([H])O)C1=CC=C(Cl)C=C1
Targets
P31749AKT1

What you can answer from here — as of May 26, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
53Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Ipatasertib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In